The White House is promoting a new "dose-stretching" strategy that uses one-fifth of a standard monkeypox vaccine dose by injecting it intradermally (under the skin) rather than into fatty tissue. The vaccine manufacturer, Bavarian Nordic, expressed concerns about the lack of data for this method. The hosts compare this to "drug dealers cutting cocaine" and reference Dr. Peter McCullough's theories on vaccine design.